Quarterly Results (unaudited)

Quarterly results are determined in accordance with the accounting policies used for annual data and include certain items based upon estimates for the entire year. All fiscal quarters include results for 13 weeks except for the quarter ended August 1, 2015, which included 14 weeks.

Revenues attributable to the acquisition of Animal Health International, Inc. are $403,580, $406,588, $414,028 and $171,922 for the quarters ended April 30, 2016, January 30, 2016, October 31, 2015 and August 1, 2015, respectively. Operating income attributable to the acquisition of Animal Health International, Inc. is $15,034, $9,827, $10,716 and $1,653 for the quarters ended April 30, 2016, January 30, 2016, October 31, 2015 and August 1, 2015, respectively.



	Quarter Ended
	April 30, 2016⁽¹⁾		January 30, 2016			October 31, 2015			August 1, 2015
Net sales	$	1,453,770	$	1,400,853		$	1,389,210		$	1,142,870
Gross profit	363,741		339,864			330,899			288,244
Operating income from continuing operations	106,344		95,729			83,463			62,177
Net income from continuing operations	65,620		57,190			42,563			20,311
Net income (loss) from discontinued operations	—		(750		)	(7,142		)	9,392
Net income	65,620		56,440			35,421			29,703
Basic earnings (loss) per share:
Continuing operations	$	0.69	$	0.60		$	0.43		$	0.20
Discontinued operations	—		(0.01		)	(0.07		)	0.10
Net basic earnings per share	$	0.69	$	0.59		$	0.36		$	0.30
Diluted earnings (loss) per share:
Continuing operations	$	0.68	$	0.60		$	0.43		$	0.20
Discontinued operations	—		(0.01		)	(0.07		)	0.10
Net diluted earnings per share	$	0.68	$	0.59		$	0.36		$	0.30



	Quarter Ended
	April 25, 2015		January 24, 2015		October 25, 2014		July 26, 2014
Net sales	$	1,035,061	$	958,628	$	978,220	$	938,956
Gross profit	288,203		262,442		259,287		250,617
Operating income from continuing operations	89,073		77,377		72,140		65,996
Net income from continuing operations	53,459		46,434		41,865		38,325
Net income (loss) from discontinued operations	11,059		8,242		11,913		11,964
Net income	64,518		54,676		53,778		50,289
Basic earnings (loss) per share:
Continuing operations	$	0.54	$	0.47	$	0.42	$	0.39
Discontinued operations	0.11		0.08		0.12		0.12
Net basic earnings per share	$	0.65	$	0.55	$	0.54	$	0.51
Diluted earnings (loss) per share:
Continuing operations	$	0.54	$	0.47	$	0.42	$	0.38
Discontinued operations	0.11		0.08		0.12		0.12
Net diluted earnings per share	$	0.65	$	0.55	$	0.54	$	0.50

(1)

During the first quarter of fiscal 2016, we incurred $9,302, or $0.09 per diluted share from continuing operations on an after-tax basis, of transaction costs related to the acquisition of Animal Health International, Inc. Also during the first quarter of fiscal 2016, we approved a one-time repatriation of approximately $200,000 of foreign earnings. This one-time repatriation reduced the overall costs of funding the acquisition of Animal Health International, Inc. In addition, certain foreign cash at Patterson Medical was required to be repatriated as part of the sale transaction. The tax impact of the repatriation recorded during the first quarter of fiscal 2016 was $11,800, or $0.12 per diluted per share from continuing operations on an after-tax basis.